Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry

Research output: Contribution to journalLetterResearchpeer-review

Original languageEnglish
JournalAnnals of the Rheumatic Diseases
Volume75
Issue number4
Pages (from-to)785-6
Number of pages2
ISSN0003-4967
DOIs
Publication statusPublished - Apr 2016

    Research areas

  • Adult, Aged, Antirheumatic Agents, Arthritis, Psoriatic, Arthritis, Rheumatoid, Denmark, Female, Humans, Incidence, Male, Middle Aged, Multiple Sclerosis, Registries, Risk Factors, Spondylitis, Ankylosing, Tumor Necrosis Factor-alpha, Letter, Research Support, Non-U.S. Gov't

ID: 164533422